We are live on
!
Find out more
GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
1-Year Est. Return
21.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.9%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$447M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow
% of AUM
101.18%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
260
New
260
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 2 |
CELG
Celgene Corp
CELG
|
+$16.3M |
| 3 |
Amgen
AMGN
|
+$12.9M |
| 4 |
Southwest Airlines
LUV
|
+$12.3M |
| 5 |
Apple
AAPL
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.33% |
| 2 | Consumer Staples | 13.46% |
| 3 | Industrials | 12.37% |
| 4 | Energy | 9.97% |
| 5 | Technology | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Energy Transfer Partners
ET
$69.5B
| $1.43M | 0.32% |
+95,860
| New | +$1.4M |
|
77
EOG Resources
EOG
$74.4B
| $1.43M | 0.32% |
+21,680
| New | +$1.39M |
|
78
Williams Companies
WMB
$85.8B
| $1.4M | 0.31% |
+43,236
| New | +$1.56M |
|
79
Macerich
MAC
$7.52B
| $1.39M | 0.31% |
+22,795
| New | +$1.5M |
|
80
AbbVie
ABBV
$465B
| $1.35M | 0.3% |
+32,765
| New | +$1.43M |
|
|
EEP
81
DELISTED
Enbridge Energy Partners
EEP
| $1.35M | 0.3% |
+44,340
| New | +$1.32M |
|
82
Yum! Brands
YUM
$41.4B
| $1.32M | 0.29% |
+26,389
| New | +$1.31M |
|
83
Duke Energy
DUK
$101B
| $1.3M | 0.29% |
+19,293
| New | +$1.36M |
|
84
American Tower
AMT
$79.9B
| $1.29M | 0.29% |
+17,700
| New | +$1.41M |
|
85
iShares MSCI Emerging Markets ETF
EEM
$28B
| $1.28M | 0.29% |
+33,240
| New | +$1.38M |
|
86
Lumen
LUMN
$6.38B
| $1.26M | 0.28% |
+35,674
| New | +$1.3M |
|
87
Lowe's Companies
LOW
$122B
| $1.24M | 0.28% |
+30,393
| New | +$1.22M |
|
88
Cigna
CI
$79.6B
| $1.19M | 0.27% |
+16,425
| New | +$1.11M |
|
89
Ford
F
$59.6B
| $1.19M | 0.27% |
+76,627
| New | +$1.1M |
|
90
Goldman Sachs Group Inc Series C Preferred Stock
GS.PRC
$153M
| $1.16M | 0.26% |
+48,150
| New | +$1.17M |
|
91
Vodafone
VOD
$37.7B
| $1.13M | 0.25% |
+38,600
| New | +$1.15M |
|
|
EMC
92
DELISTED
EMC CORPORATION
EMC
| $1.1M | 0.25% |
+46,600
| New | +$1.1M |
|
93
ConocoPhillips
COP
$139B
| $1.08M | 0.24% |
+17,865
| New | +$1.09M |
|
94
iShares US Oil & Gas Exploration & Production ETF
IEO
$549M
| $1.07M | 0.24% |
+14,990
| New | +$1.09M |
|
95
Starbucks
SBUX
$118B
| $1.07M | 0.24% |
+32,718
| New | +$1.02M |
|
96
Vanguard FTSE Developed Markets ETF
VEA
$225B
| $1.07M | 0.24% |
+29,930
| New | +$1.12M |
|
97
iShares Biotechnology ETF
IBB
$9.55B
| $1.06M | 0.24% |
+18,285
| New | +$1.06M |
|
98
ManpowerGroup
MAN
$2.58B
| $1.06M | 0.24% |
+19,300
| New | +$1.06M |
|
99
Xerox
XRX
$360M
| $1.05M | 0.24% |
+43,995
| New | +$1.03M |
|
100
Hershey
HSY
$37.2B
| $1.04M | 0.23% |
+11,694
| New | +$1.03M |
|
Similar funds
KRC
GS
PAAMCP
B
JPCCM
NBC
NTC
SD
Gerald L. Ray & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Gerald L. Ray & Associates, which disclosed 260 positions worth $447M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Industrials.
- Gerald L. Ray & Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
- Gerald L. Ray & Associates's ten largest holdings make up 25% of its $447M portfolio in Q2 2013.
- Gerald L. Ray & Associates disclosed 260 positions in Q2 2013, its first 13F filing on record.
Based on Gerald L. Ray & Associates's 13F filing for Q2 2013, filed 1 Aug 2013.